» Authors » Caroline E Weibull

Caroline E Weibull

Explore the profile of Caroline E Weibull including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 437
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weibull C, Sjoberg J, Dickman P, Bjorkholm M
Acta Oncol . 2023 Sep; 62(12):1942-1944. PMID: 37708099
No abstract available.
2.
Nikkarinen A, Lokhande L, Amini R, Jerkeman M, Porwit A, Molin D, et al.
Blood Adv . 2023 Jun; 7(18):5304-5313. PMID: 37389827
The outcome for patients with mantle cell lymphoma (MCL) has drastically improved with new treatments directed toward the tumor immune microenvironment, where macrophages play an important role. In MCL, the...
3.
Entrop J, Weibull C, Smedby K, Jakobsen L, Ovlisen A, Glimelius I, et al.
Br J Haematol . 2023 Jun; 202(4):785-795. PMID: 37325886
Previous studies concerning reproductive patterns among non-Hodgkin lymphoma (NHL) survivors are scarce and those available have reported conflicting results. Treatment regimens vary considerably between aggressive and indolent NHL and studies...
4.
Entrop J, Weibull C, Smedby K, Jakobsen L, Ovlisen A, Molin D, et al.
Int J Cancer . 2023 Apr; 153(4):723-731. PMID: 37119033
Childbirth rates in classical Hodgkin lymphoma (cHL) survivors have historically been reduced compared to the general population. Understanding if contemporary treatment protocols are associated with reduced fertility is crucial as...
5.
Weibull C, Boman S, Glimelius B, Syk I, Matthiessen P, Smedby K, et al.
Acta Oncol . 2023 Apr; 62(4):342-349. PMID: 37029990
Objectives: To facilitate high-quality register-based research on colorectal cancer (CRC) in Sweden by constructing a database consisting of CRC patients, matched comparators, and relatives. Material And Methods: Patients with adenocarcinoma...
6.
Moreno Berggren D, Garelius H, Willner Hjelm P, Nilsson L, Rasmussen B, Weibull C, et al.
Leukemia . 2023 Mar; 37(5):1103-1112. PMID: 36928008
In this population-based study, we aimed to characterize and compare subgroups of therapy-related Myelodysplastic syndromes (t-MDS) and define the implications of type of previous treatment and primary disease. We combined...
7.
Weibull C, Wasterlid T, Wahlin B, Andersson P, Ekberg S, Lockmer S, et al.
Hemasphere . 2023 Feb; 7(3):e838. PMID: 36844185
In follicular lymphoma (FL), progression of disease ≤24 months (POD24) has emerged as an important prognostic marker for overall survival (OS). We aimed to investigate survival more broadly by timing...
8.
Lundqvist E, Hed Myrberg I, Boman S, Saraste D, Weibull C, Landerholm K, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765646
Incidence of early-onset (<50 years) colorectal cancer (EOCRC) is increasing in developed countries. The aim was to investigate autoimmune and metabolic conditions as risk factors for EOCRC. In a nationwide...
9.
Rosander E, Holm T, Sjovall A, Hjern F, Weibull C, Nordenvall C
BJS Open . 2022 Nov; 6(6). PMID: 36417311
Background: High hospital volume has been shown associated with improved survival in patients with several cancers. The aim of this nationwide cohort study was to investigate whether hospital volume affects...
10.
Radkiewicz C, Bruchfeld J, Weibull C, Jeppesen M, Frederiksen H, Lambe M, et al.
Am J Hematol . 2022 Sep; 98(1):23-30. PMID: 36178436
It is well established that the male sex is associated with increased risk for, as well as poorer survival of, most cancers. A similar pattern has been described in lymphomas...